Sastasundar Ventures Ltd

Sastasundar Ventures Ltd

$SASTASUNDRHealthcare Service ProviderNSEBSE

Sastasundar Ventures Ltd (SASTASUNDR) last traded at ₹296, a market capitalisation of ₹942 crore. Over the past 52 weeks the stock has ranged between ₹252 and ₹375. Sastasundar Ventures Ltd last reported results for the quarter ended Jun 2026, with sales of ₹447 crore and net profit of ₹1.99 crore. The next scheduled event is an analyst meet on 31 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.

Sastasundar Ventures Ltd share price and key metrics

Current price
₹296
Market cap
₹942 cr
Book value
₹201
ROE
0.29%
ROCE
-0.05%
Dividend yield
0.00%
52w high / low
375/252

Metrics as of 25 Aug 2026. Not real time.

Sastasundar Ventures Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹447 cr, up 49.7% from ₹298 cr a year earlier. Net profit was ₹1.99 cr, down 92.5% year on year.

Sastasundar Ventures Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales274281286298301346374447
Expenses278305311292324356399455
Operating profit-4.72-23.7-25.26.06-22.61-10.36-25.19-8.38
OPM %-1.73%-8.43%-8.82%2.03%-7.50%-3.00%-6.74%-1.88%
Other income-167.39-14.0621.9125.385.3413.6212.812.83
Interest0.060.050.010.090.040.170.490.59
Depreciation1.451.431.341.171.332.171.941.89
Profit before tax-173.62-39.24-4.6430.18-18.640.92-14.821.97
Tax %-13.17%1.99%-478.45%11.90%-17.17%59.78%-12.48%-0.51%
Net profit-154.78-37.817.5726.59-15.440.37-12.971.99
EPS (₹)-34.39-8.474.307.52-3.990.36-3.510.80

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Sastasundar Ventures Ltd annual results

Sastasundar Ventures Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5511,7981,0601,4321,1591,3191,468
Operating profit-101,114-107-24-19-52-67
OPM %-1.9%62%-10%-1.7%-1.6%-4.0%-4.5%
Net profit-17865-996-134-1-26
EPS (₹)-3.27197.05-22.702.79-28.660.37-6.34

TTM is the trailing twelve months to the most recent quarter.

Sastasundar Ventures Ltd growth and returns

Compounded Sales Growth
10 Years
31%
5 Years
19%
3 Years
8%
TTM
29%
Compounded Profit Growth
10 Years
7%
5 Years
17%
3 Years
27%
TTM
-154%
Stock Price CAGR
10 Years
17%
5 Years
1%
3 Years
1%
1 Year
10%
Return on Equity
10 Years
-4%
5 Years
-2%
3 Years
2%
Last Year
0%

Sastasundar Ventures Ltd shareholding pattern

Promoters held 74.07% at Jun 2026, broadly unchanged since Jun 2025. FIIs 2.29% and DIIs 2.60%.

Sastasundar Ventures Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters73.92%73.93%74.11%74.24%74.24%74.69%74.84%74.07%
FIIs0.99%1.71%1.60%1.88%2.04%2.25%2.17%2.29%
DIIs1.98%1.85%2.06%2.09%2.07%2.07%2.60%2.60%
Public23.11%22.50%22.21%21.79%21.65%20.99%20.38%21.02%
No. of shareholders15,36014,09313,69313,45213,01212,28711,84511,502

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Upcoming Sastasundar Ventures Ltd events

The next scheduled event is an analyst meet on 31 Aug 2026.

  • Analyst meetGIA Healthcare Day Group Conference

See the full results calendar for every Indian company reporting in the next 30 days.

Sastasundar Ventures Ltd corporate filings

  • Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Health X Platform Ltd has issued an intimation regarding an upcoming analyst/investor…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-Earnings Call TranscriptCompany Updatehigh impact
    Filing PDF

    Cruxal's analysis: Health X Platform Limited delivered a strong Q1 FY27 performance with revenue from…

    Read the full analysis
  • Disclosure under Listing Regulations - Submission of Audio recording of the Earnings Conference call for Q1 FY27Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Health X Platform Limited has formally submitted the audio recording of its earnings…

    Read the full analysis
  • Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended 30th June, 2026Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Health X Platform Limited (formerly Sastasundar Ventures Limited) reported its unaudited…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-Investor PresentationCompany Updatehigh impact
    Filing PDF

    Cruxal's analysis: Health X Platform Limited has released an investor presentation detailing its Q1 FY27…

    Read the full analysis
  • Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th August, 2026Board Meetingmedium impact
    Filing PDF

    Cruxal's analysis: Health X Platform Limited (formerly Sastasundar Ventures Limited) reported consolidated…

    Read the full analysis
  • Intimation of Schedule of the Earnings Conference Call for Q1 of FY2026-27 and registration Link thereofCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Health X Platform Limited has announced an earnings conference call to discuss its…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Sastasundar Ventures Ltd

Cruxal reads every Sastasundar Ventures Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Sastasundar Ventures Ltd (SASTASUNDR) Results, Financials & Share Price | Cruxal